Conferences

Quickly consult our archives filtering by year :

Swiss HLG invites you to use our online form to give feedback and stay in touch in such challenging times:

BD&L in 2021

21st & 22nd April 2021

It is a great pleasure to inform you about the collaboration between Swiss HLG and our international network IPLS (www.ipls.online) for the next spring conference “Rebound & Recover” planned for 21st-22nd April.

At this occasion, you’ll have the opportunity to set up virtual one-to-one business meetings with your peers, without traveling, over 2 days and participate to several conferences to keep you up-to-date about the trends in our industry. This will help you and your business during this pandemic to substitute your business travels.

Take advantage of the early bird rate and register asap at: www.ipls.online.  If you need any help please contact Adam Collins at acollins@ngaevents.co.uk or Andrew Dean at andrew.dean@presentvalueltd.com

Several sponsoring opportunities are also offered, to give more visibility to your company and business inside this network of over 1’700 BD&L professionals. Join current sponsors:

REGISTRATION OPEN

Financing and Deal-making in turbulent times, 2nd March 2021, 3.00pm – 6.00pm CET

IPLS Online Event: 16th – 17th September 2020

IPLS Bright Online Conference is now open for registration.

Full access to the event website where the presentations will be broadcast, video content, details of the programme and speakers & online partnering system. Full Access Pass – €100.00 (EUR).

Simply click here to register!

EVENT SCHEDULE

Wednesday 16th September 2020

08.00 – 18.00Online Partnering – 25 minutes per meeting
MORNING SESSION
08.45Registration
09.00Welcome & Introduction
09.05Keynote Address
SHAUN GRADY
AstraZeneca
09.25Covid-19: The First 6 Months
ANDREW DEAN
Present Value
09.45Biopharmaceutical Sector: Financing and Deal Making Outlook 
STEPHANIE LEOUZON
Torreya
10.05Global Pipeline Overview
10.25Closing Remarks
10.30Close of Morning Session
AFTERNOON SESSION
15.15 – 15.30Registration
15.30Innovation from The Crick
BARBARA DOMAIN HAYMAN
The Francis Crick Institute 
15.50What’s Hot in Oncology Deal Making- Where is the Low Hanging Fruit?
CHRIS SHELDON
AstraZeneca
16.10Gene Therapy Comes of Age
16.30BREAK
16.40The Application of AI in Rare Diseases
BRUCE E. BLOOM & CLARA TANG
Healx
17.00Pricing and Market Access in Rare Diseases
RAVI SODHA
Sodha Pharma Consulting
17.20Closing Remarks
17.25Close of Day 1

Thursday 17th September

08.00 – 18.00Online Partnering – 25 minutes per meeting
08.45Registration
09.00Panel Discussion: Building Business Development Relationships in Covid-19 times

GEORG BUCHNER
Helsinn Healthcare

CHRIS VAES
J&J

JEAN-MARC SEQUIER
Novartis

TORU J. SEO
Pfizer

MICHAEL CROWLEY
F. Hoffann-La Roche
09.45Panel Discussion: Impact of Covid-19 on Promotional Activities, Could Covid-19 Boost a Change of the Current Paradigm?

LARS BOERGER
Alliance Pharma

BENOIT SLAVICEK
Mundipharma
10.30Closing Remarks
10.35Close of IPLS Bright Online

 “DEAL-MAKING IN THE ROUGH“

The Swiss HLG, a non-profit association of Business Development and Licensing professionals, held its 31st  Conference titled “DEAL-MAKING IN THE ROUGH”, in a beautiful setting in the Swiss Alps. The topic of discussion focused on the fact we are living in provoking times: The pharmaceutical and biotech industry as a whole and the professional business developers, alliance managers and dealmakers have to cope with a disruptive and changing environment in which deal making will become more and more complex and ambitious. 

Over two and a half days, more than 85 delegates from Switzerland, Europe, the US and Asia gathered in the Swiss Alps to explore and discuss new trends in partnering and deal-making in the current tumult of our industry with the overall objective to capture the maximum value with professional capabilities and high-calibre talents.

Read More…

Join us, become a member !

Join Swiss HLG
as a member

Newsletter

Keep up to date with the latest information by signing up to our newsletter

Why it's worth joining us !

Learn more about Swiss HLG
and our initiatives